Consolidated Statements of Cash Flows The accompanying notes ar an integral part of these consolidated statements. Cardinal Health, Inc. Annual Report 2000 35 Fiscal Year Ended June 30, (In millions) 2000 1999 1998 Cash Flows from Operating Activities: Net earnings  $ 679.7 $ 481.0  $  448.5  Adjustments to reconcile net earnings to net cash from operating activities: Depreciation and amortization 245.9 238.2  218.4  Provision for deferred income taxes 127.6 132.4  90.1  Provision for bad debts 34.4 29.7  23.4  Change in operating assets and liabilities, net of effects from acquisitions: Increase in trade receivables (110.3) (214.5) (211.7) Increase in inventories (926.3) (317.9) (474.3) Increase in net investment in sales-type leases (159.5) (282.3) (103.3) Increase in accounts payable 678.8 229.7  520.9  Other operating items, net 67.9 81.3  60.0  Net cash provided by operating activities 638.2 377.6  572.0  Cash Flows from Investing Activities: Acquisition/divestiture of subsidiaries, net of cash acquir ed (67.5) (147.5) (45.8) Proceeds from sale of property and equipment 39.7  57.9  10.8  Additions to property and equipment (307.8) (326.0) (286.3) Purchase of marketable securities available for sale (7.7) (15.6) (14.2) Proceeds from sale of marketable securities available for sale 56.0  13.5  10.6  Other –  –  (4.7) Net cash used in investing activities (287.3) (417.7) (329.6) Cash Flows from Financing Activities: Net change in commercial paper and short-term debt 400.7 (207.4) (89.2) Reduction of long-term obligations (157.9) (118.5) (49.1) Proceeds from long-term obligations, net of issuance costs 0.5 223.7  111.4  Proceeds from issuance of Common Shares 87.2  62.1  59.2  Dividends on common shares, minority interests and  cash paid in lieu of fractional shar es (28.0) (75.7) (52.3) Purchase of treasury shares and other (334.2) (47.8) (155.0) Net cash used in financing activities (31.7) (163.6) (175.0) Net Increase (Decrease) in Cash and Equivalents 319.2 (203.7) 67.4  Cash and Equivalents at Beginning of Year 185.4  389.1  321.7  Cash and Equivalents at End of Year $ 504.6 $ 185.4  $  389.1 